Avatrombopag (Avatrombopag) brief description

Avatrombopag, also known as avatrombopag, is an innovative drug specifically used to treat thrombocytopenia. The drug has been clinically proven to have good efficacy and good safety, so it has been approved for marketing use. This leaflet is intended to provide patients with necessary information about this drug and guidance on its use.

1. Drug ingredients

The main ingredient of this product isavatrombopag, which is a thrombopoietin (TPO) receptor agonist. It promotes platelet production by stimulating the proliferation and differentiation of megakaryocytes in the bone marrow.

2. Indications

Avatrombopag is mainly used to treat thrombocytopenia associated with chronic liver disease and immune thrombocytopenia (ITP). It can help patients increase their platelet count and reduce the risk of bleeding.

3. Usage and dosage

Please use it as directed by your doctor. It is generally recommended to take it with food and an appropriate amount of water. The dosage of the drug will be adjusted according to the patient's specific condition to achieve the best therapeutic effect.

4. Adverse reactions

Adverse reactions that avatrombopag may cause include headache, fatigue, nausea, etc. In addition, allergic reactions such as itching and rash may also occur. If severe discomfort occurs, seek medical attention immediately.

4. Taboos and Precautions

1. It is forbidden for those who are allergic to the ingredients of this product.

2. Pregnant and lactating women should be careful when using this medication and consult a professional doctor.

3. During the period of using this product, the platelet count should be monitored regularly and the treatment plan should be adjusted in a timely manner.

4. If you are using other drugs, please inform your doctor to avoid drug interactions.

6. Storage

Please store this product in a cool, dry place at room temperature, away from direct sunlight. Please keep this product out of reach of children.

7. R&D manufacturers and listing information

This product was developed byDova Pharmaceuticals and is currently on the market in my country. Patients can purchase and use it with doctor's advice. In addition, this drug is a medical insurance drug and can be reimbursed by patients. In addition, there are generic drugs of this product in markets such as Laos, with prices ranging from several hundred to one thousand, providing patients with more treatment options.

In conclusion, avatrombopag is an effective treatment for thrombocytopenia. Before use, please read the instructions carefully and use it strictly in accordance with your doctor's instructions. If you have any questions or discomfort, please consult your doctor promptly.